Intrexon | Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Agenus USD 3.46M 6.08M 2025-09
Alaunos Therapeutics USD 1.94M 941K 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Incyte USD 3.58B 650.78M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Ligand Pharmaceuticals USD 664.52M 596.85M 2025-09
MacroGenics USD 80.13M 50.56M 2025-09
MannKind USD 127.39M 70.39M 2025-09
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Veracyte USD 315.57M 96.07M 2025-09
Xencor USD 28.29M 16.15M 2025-09


Intrexon Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.